Tokers & Jokers | Cannabis Stocks Soar Thursday

Canna stocks had a strong Thursday with most US and Canadian cannabis companies climbing from yesterday’s gains.

Tuesday Green Growth Brands (OTCMKTS: GGBXF) (CSE: GGB) announced the appointment of retail veteran Brian Logan CPA, as its new Chief Financial Officer. Previously, Logan worked as Vice President of Finance for Abercrombie & Fitch Co. The company also announced the $12.35M acquisition of ZLJT LLC & Arizona Natural Pain Solutions Inc, collectively referred to as “Desert Rose”. Desert Rose controls a vertically integrated license in Arizona that includes retail, cultivation, and an industrial kitchen.

Green Growth closed up 4.66% on the OTC at $4.04.

Green Growth recently initiated a hostile takeover bid for Aphria Inc (NYSE: APHA). Aphria’s subsidiary holds 10% stake in GA Opportunities, the largest shareholder in Green Growth Brands. Further, the two companies have had several dealings in the past, leaving critics of the takeover wondering if this is truly a hostile bid.

In December a short attack was launched and Aphria came under scrutiny for insider enrichment at the cost of shareholders. Aphria stands accused of purchasing a number of Latin American assets at a significant markup in order to financially benefit insiders. Currently, a class action lawsuit is being brought against the company.

Bloomberg announced today that Aphria shares have recovered all losses that followed the short seller’s report. The stock lost more than half of its value in just three days following the attack. Aphria shares now trade at a 27% premium compared to the price Green Growth Brands offered Aphria –the second widest gap of 107 deals tracked by Bloomberg — however Green Growth announced it is open to change on its bid for the company.

Aprhia ended the day up a whopping 14.10% at $8.74.

According to Tuesday’s report from Zacks, Cronos Group (NASDAQ: CRON) has gained 77.86% over the past month. Noting the company’s valuation metrics, and it’s P/E ratio of 176, Zacks gave Cronos a “strong sell” ranking. Jim Cramer recently gave Cronos a bullish endorsement, calling Cronos his second favorite cannabis pick. Earlier this week, Market Wealth announced it has initiated coverage on Cronos. Cronos was up 6.78% at the end of trading at $19.68.

Canopy Growth Corp. (NYSE: CGC) has gained 75.4% in the last month, according to Zacks, who gave the company a “hold” rating yesterday. According to Zacks, analysts expect Canopy to report annual earnings of -$1.13 per share and revenue of $200.11M. Tuesday the company announced Alan Gertner, head of retail sales, has left the company. Analysts warn investors Canopy is overbought in the near term. The company closed up 2.00% and was trading at $48.98.

Canopy-backed Slang Worldwide Inc. (CSE: SLNG) began listing on the CSE Tuesday. The cannabis branding and distribution company was valued at $480M (CA$645M). Slang had an impressive first day, climbing 33% from CA$1.50 to CA$1.99. The company closed Thursday down 0.40% at $2.49.

Organigram Holdings Inc. (OTCMKTS: OGRMF) (CVE: OGI) was recently listed among the 50 best performing stocks on the OTCQX Best Market. Today the company announced that it has surpassed the production of 1M cannabis pre-rolls since Canada’s legalization in Oct. 2018.

Monday the company announced its first quarter financial results for fiscal 2019, reporting a net revenue of $12.4M — up 287% sequentially quarter-over-quarter. Revenue adjusted for excise tax and returns rose 419% in the year-ago period.

Pi Financial upped the company’s price target from CA$8 to CA$10 Wednesday. Beacon Securities also boosted its price objective on Organigram, setting its estimated target price at CA$12, and giving the company a “buy” rating.

Organigram announced Tuesday morning that it has entered into a multi-year extraction agreement with Valens GroWorks Corp. (CSE: VGW) (OTC: VGWCF). Valens also announced a secondary purchase and sale transaction that includes 3.5M shares at $2.05 each. Altacorp Capital recently initiated coverage on Valens, giving the company a bullish boost.

Organigram climbed 5.92% on the OTC and was trading at $5.96.

Valens GroWorks Corp. gained 1.91% on the OTC and was trading at $1.85.

Recently, Curaleaf Holdings (OTCMKTS: CURLF) (CSE: CURA) received a bullish endorsement from Matt Bottomley, director of equity research and cannabis analyst with Canaccord Genuity Group — calling the company his top stock-pick of the year. Monday the company appointed Neil Davidson as Chief Financial Officer and Todd Goffman as General Counsel and Secretary. The company was trading up 5.44% at $6.48.

Currently four out of the five analysts who cover Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) have issued “buy” ratings on the company, with an average target price of $18.40. Zynerba has climbed 72.26% in the last thirty days, with a relative strength index of 69.72. The company climbed 4.17% to $5.24.

Today Tilray (NASDAQ: TLRY) announced it is expanding its global senior leadership team with four new hires: Greg Christopher as EVP of Operations, formerly with Nestle; Rita Seguin as EVP of Human Resources, formerly with Diageo; Dara Redler as General Counsel, formerly with The Coca-Cola Company; and Charlie Cain as VP of Retail, formerly with Starbucks Corporation.

Analysts’ average price target for the company hovers around $127.50, giving the stock a lot of room to grow.

Tilray took a dive this week after the company’s CEO Brendan Kennedy, who also serves as the Executive Chairman of Privateer Holdings, sold over 149K shares worth $11M of his personal stock. Privateer Holdings issued a press release pledging not to sell shares of Tilray. Currently Privateer holds 88% of Tilray’s outstanding shares.

To make matters worse, Woody Pastorius, Tilray’s Chief Revenue Officer, sold 20,578 shares the same day as Kennedy for $1.5M. Both Kennedy and Pastorius sold their shares for $74.21 each.

Tilray shares were climbed 3.88% and trading at $80.49.

According to a recent report from Simply Wall St., in the last year company insiders at The Green Organic Dutchman Holdings Ltd. (OTCMKTS: TGODF) (TSE: TGOD) have sold more shares than they have purchased.

Tuesday the The Green Organic Dutchman entered into a definitive agreement with Queen Genetics/Knud Jepsen A/S to establish two 50/50 joint ventures in Denmark.

The company is also in talks with the Greek Ministry of Agriculture and is awaiting a license for the production of medical cannabis.

The Green Organic Dutchman received a bullish endorsement from Network News Wire Tuesday. The company was trading down on the OTC by 1.83% at $2.68.

Zacks recently gave Innovative Industrial Properties Inc. (NYSE: IIPR) a “hold” rating, estimating its current fiscal-year earnings to have risen 1.8% in the last 90 days. The company released its latest investor presentation this last week, announcing it had $25.6B annual base rent and property management fees. Innovative ended the day trading up 1.18% at $61.92.

Business Insider reported today that Aurora Cannabis (NYSE: ACB) has just surpassed Apple as the favorite stock among millenials on the popular trading app Robinhood. Monday, Market Wealth initiated coverage on Aurora and Cronos. Shares of Aurora climbed 2.31% to $7.09.

Neptune Wellness Solutions (NASDAQ: NEPT) has risen 19.26% over the last four weeks. Zacks gave the company a “strong buy” rating last week, with a price target of $6.06. Neptune climbed 2.43% and was trading at to $3.37.

Acreage Holdings Inc.’s (OTCMKTS: ACRGF) (CNSX: ACRG.U) was up on the OTC by 2.70% and trading at $22.51 at the end of the day.

GW Pharmaceuticals (NASDAQ: GWPH) has been burdened with good news recently. Out of the 12 analysts covering the company, all but one has a “buy” rating for GW. Zacks provided estimates for GW Pharmaceuticals PLC-‘s earnings with an expected earnings of $2.97 per share for the current quarter. According to Zacks, who reiterated its “hold” rating on the company — announced GW is expected to gain 4.2% in the next quarter. Piper Jaffray also issued estimates for the company at $0.02 EPS for Q3 2020 and $0.06 EPS for Q4 2020. Piper Jaffray currently lists GW Pharmaceuticals with an “overweight” rating. The company climbed 1.64% and was trading at $142.75.

Hexo Corp. (NYSE: HEXO) (TSE: HEXO) announced the closing of a $43.3M share offering Wednesday. The company priced the public offering of 7.7M shares of common stock at the price of CA$6.50 for the gross proceeds of CA$50.05M. Hexo began trading on the New York Stock Exchange last week. The company ended the day trading up 6.79% and trading at $5.66.

MedMen Enterprises Inc (OTCMKTS: MMNFF) (CNSX: MMEN) was lost 2.31% on the OTC and trading at $3.54.

MJardin Group Inc. (OTCMKTS: MJARF) (CSE: MJAR) received an “underperform” rating from Cornerstone Investments. With a 70% plunge since its reverse takeover in November, the company has had one of the worst performances among new listings.

Mjardin gained 0.54% and was trading at $2.95.

KushCo Holdings Inc.’s (OTCMKTS: KSHB) was downgraded by Zacks to a “Sell” rating Monday. Recently the company’s Chairman Nicholas Kovacevich sold 200,000 shares of the company for a total value of $1.208B. Kushco was trading down 1.27% at $5.44.

Yesterday Trulieve Cannabis Corp. (OTCMKTS: TCNNF) (CSE: TRUL) was recognized by the Minorities of Medical Marijuana as their 2018 Diversity and Inclusion Champion of the Year Award recipient. Russell Stanley of Beacon Securities initiated coverage on the company last week giving the company a “buy” rating with a price target of CA$28.00.

Last Friday, about 98 million shares of the company were unlocked, representing 89% of Trulieve’s outstanding shares. The company announced that approximately 75.5M subordinate voting shares held by the company’s founders won’t be sold prior to July 25, 2019. Trulieve was trading up 7.15% on the OTC at $11.43.

Monday Cresco Labs (OTCMKTS: CRLBF) (CSE: CL) announced the appointment of Tom Manning as Chairman of the Board of Directors. Manning is the CEO of Dun & Bradstreet, a global corporate information provider and data analytics company. Cresco was up 3.98% on the OTC and trading at $7.09.

Earlier this week, Auxly Cannabis Group Inc. (OTCMKTS: CBWTF) announced it has signed a definitive agreement with Curative Cannabis to acquire 46% of Curative’s common shares.was recently granted an “outperform” rating from AltaCorp. Auxly was up 1.19% with a price at $0.72.

FSD Pharma (OTCMKTS: FSDDF) was up 8.99% and was trading at $0.27.

iAnthus Capital Holdings (OTCMKTS: ITHUF) was recently listed among the 50 best performing stocks on the OTCQX Best Market. Northland Capital Markets recently initiated coverage on iAnthus, giving the company with an “outperform” rating and a $9.50 price target. iAnthus gained 1.57% and was trading at $5.18.

Namaste Technologies Inc. (OTCMKTS: NXTTF) (TSXV: N) plans to capitalize off Israel’s recent decision to legalize the export of medical cannabis. With a supply agreement and a ten percent stake in Israel based Cannbit Ltd., Namaste plans to export medical cannabis. Namaste lost 1.87% on the OTC and was trading at $1.05.

MariMed Inc (OTCQB: MRMD) closed the day down with a massive 9.21% slide, trading at $4.04.

MediPharm Labs (TSXV: LABS) (OTCQB: MLCPF) lost 3.16% on the OTC and was trading at $1.44 at the close of trading.

TerrAscend Corp (CSE: TER) (OTCMKTS: TRSSF) climbed 4.26% closing out the day at $6.67 on the OTC.

Sunniva Inc (CSE: SNN) (OTCQB: SNNVF) announced changes to its California leadership team, promoting Kevin Wilkerson tp President of Sun CA Holdings. Last week the company announced a $10M non-brokered offering to provide working capital in response to a high demand. The company was trading down by 5.37% at $3.45.

CannTrust Holdings Inc. (OTCMKTS: CNTTF) (TSX: TRST) gained 10.01% on the OTC, trading at $7.70.

Ranked as the second best-performing stock on the OTCQX Best Market, Origin House (OTCMKTS: ORHOF) (CNSX :OH) had a return of 58.9% in 2018. Earlier this week, Origin House advanced $750,000 in financing to Utopia Cannabis. The funds will go towards the purchase of Utopia’s manufactured cannabis products. Origin also announced Monday that it has signed an exclusive agreement with NBA star Al Harrington’s Viola to produce, package, and sell all Viola products in California. The company was trading up 3.02% and trading at $7.29.

New Age Beverage Co. (NASDAQ: NBEV) is expected to post $14.06M in sales for the current quarter, and $52.23M for the current fiscal year, according to Zacks. The company announced it has signed a definitive agreement to acquire Morinda Holdings Inc. for $85M. Aegis analyst Rommel Dionisio reiterated his “buy” rating and doubled his price target for the company from $4 to $8. ValuEngine also upgraded the stock from a “hold” position to a “buy” rating. New Age saw a gain of 0.99% Tuesday and was trading at $7.11.

Horizons ETFs Management Canada Inc. (TSE: HMMJ) gained 4.01% and was trading at $20.49.

The Horizons Marijuana Life Sciences Index ETF (OTC: HMLSF) climbed 4.34% and trading at $15.59.

ETFMG Alternative Harvest ETF (NYSEARCA: MJ) The ETF was trading up 3.99% at $35.16.

The North American Marijuana Index tracks the leading cannabis stocks in the US and Canadian Sectors. The Index gained 2.31% and was trading at $289.59.

1 thought on “Tokers & Jokers | Cannabis Stocks Soar Thursday”

  1. Pingback: Daily Cannabis News Roundup | February 1, 2019 - The Morning Blunt